Emollients: Clinical Trials

15 trials of Emollients, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 4 unknown, 1 not yet recruiting. 9 Not applicable, 2 Phase 2, 2 Phase 4, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 5, Unknown 4
Phase 22Completed 2
Phase 42Completed 1, Not yet recruiting 1
Phase 31Completed 1

Follow Emollients: new trials by email Literature Review of Emollients trials Research Report on Emollients

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Baseline Dermoscopic Vascular Score and Response to Oral Tranexamic Acid in Facial Melasma
Tranexamic acid, Standardised sunscreen and emollient - Melasma
Phase 4Not yet recruitingAllied Hospital Faisalabad1282026-11-012026-10-19
Effect of Extracorporeal Shockwave Therapy on Pruritus in Neurodermatitis Patients
Shockwave therapy, Emollients & corticosteroids - Neurodermatitis
Not applicableCompletedCairo University342024-12-152026-03-09
Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial
dupilumab, Topical emollient (moisturizer) - Moderate-to-Severe Atopic Dermatitis, Atopic Eczema
Phase 4CompletedRegeneron Pharmaceuticals1242023-01-112026-05-27
Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis
LimpiAD 2,5% plus cream, Vehicle, Emollient - Atopic Dermatitis
Not applicableUnknownAileens Pharma SRL2002022-04-212024-02-06
CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS
Cosmetic study - Atopic Dermatitis
CompletedCosmetique Active International632021-12-202023-03-24
Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic Dermatitis
LimpiAD cream 2,5% plus, Vehicle, Emollient - Atopic Dermatitis
Not applicableUnknownAileens Pharma SRL2002021-03-102024-02-06
Neonatal Bacterial Colonization Study
Skin antisepsis, Emollient - Neonatal SEPSIS, Prematurity
Not applicableUnknownUniversity of Stellenbosch802019-03-042019-04-01
Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis
Dupilumab, Placebo, Emollient (moisturizer) - Atopic Dermatitis
Phase 3CompletedSanofi1652018-12-192023-12-19
Emollient Therapy In Preterm & Low Birth Weight Neonates: A Randomized Clinical Trial
Emollient (sunflower oil) - Weight Gain
Not applicableCompletedDr. Abdul Ahad Jamshaid1402018-01-012020-11-06
Regional Differences of Cutaneous Irritation and Its Effect on Skin Barrier Recovery
Sodium lauryl sulphate induced irritation, Emollient, moisturizing cream - Irritant Contact Dermatitis
Not applicableCompletedUniversity of Split, School of Medicine252017-08-292017-10-02
Emollient Therapy for Severe Acute Malnutrition
Topical emollient (Sun Flower seed oil) - Child Malnutrition, Malnutrition in Children
Not applicableCompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh2122016-01-012020-01-09
Addition of a Topical Steroid to a Topical Retinoid in Acne Patients
Triamcinolone, Tretinoin, Emollient - Acne
Not applicableUnknownCarilion Clinic202015-06-012016-03-10
Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)
Dupilumab, Placebo, Background treatment - Atopic Dermatitis (AD)
Phase 2CompletedRegeneron Pharmaceuticals542013-12-312020-03-18
Topical Emollient Therapy
Topical Emollient - Blood Stream Infection
Not applicableCompletedAga Khan University2582011-07-012015-04-07
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
emollient (Cetaphil cream) - Atopic Dermatitis
Phase 2CompletedOregon Health and Science University222006-11-012017-07-11

Conditions studied

Dermatitis, Atopic (7)  ·  Eczema (2)  ·  Premature Birth (2)  ·  Acne Vulgaris (1)  ·  Child Nutrition Disorders (1)  ·  Cross Infection (1)  ·  Dermatitis, Irritant (1)  ·  Hyperpigmentation (1)  ·  Malnutrition (1)  ·  Melanosis (1)  ·  Neonatal Sepsis (1)  ·  Neurodermatitis (1)  ·  Pruritus (1)  ·  Sepsis (1)  ·  Weight Gain (1)

Sponsors

Aileens Pharma SRL (2)  ·  Regeneron Pharmaceuticals (2)  ·  Aga Khan University (1)  ·  Allied Hospital Faisalabad (1)  ·  Cairo University (1)  ·  Carilion Clinic (1)  ·  Cosmetique Active International (1)  ·  Dr. Abdul Ahad Jamshaid (1)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (1)  ·  Oregon Health and Science University (1)  ·  Sanofi (1)  ·  University of Split, School of Medicine (1)  ·  University of Stellenbosch (1)

Countries

Pakistan (3)  ·  United States (3)  ·  Italy (2)  ·  Bangladesh (1)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Croatia (1)  ·  Egypt (1)  ·  South Africa (1)

Top investigators

Abdul Ahad Jamshaid, FCPS MRCPCH (1)  ·  Amara Safdar, MBBS, FCPS (1)  ·  Daniele Miranda, MD (1)  ·  Dario Leskur, MPharm (1)  ·  Doaa Atef Aly, PhD (1)  ·  Eric Simpson, MD (1)  ·  Francesca Farnetani, Prof (1)  ·  K M Shahunja, MBBS (1)  ·  Michael Kolodney, MD, PhD (1)  ·  Noha Zakaria Tawfik, PhD (1)  ·  Rehana A Salam, MSc (1)  ·  Ruggiero Giuseppe, MD (1)

Results publications

PMID 25637007, PMID 30194992, PMID 30637727, PMID 31252032, PMID 32509290, PMID 34092255, PMID 34195575, PMID 34386216, PMID 36525340, PMID 37575149

NIH funding

K43TW010682 (1)